专题报道 |
|
|
|
|
细菌RNA聚合酶抑制剂的分子生物学机制研究进展 |
史婧1( ),冯钰1,2 |
1. 浙江大学医学院生物物理系, 浙江 杭州 310058 2. 浙江大学医学院附属邵逸夫医院病理科, 浙江 杭州 310016 |
|
New inhibitors targeting bacterial RNA polymerase |
SHI Jing1( ),FENG Jue1,2 |
1 |
GRUBER T M , GROSS C A . Multiple sigma subunits and the partitioning of bacterial transcription space[J]. Annu Rev Microbiol,2003,57:441-466.
|
2 |
ZHANG G , CAMPBELL E A , MINAKHIN L , et al . Crystal structure of thermus aquaticus core RNA polymerase at 3.3 ? resolution[J]. Cell,1999,98(6):811-824.
|
3 |
MURAKAMI K S . X-ray crystal structure of Escherichia coli RNA polymerase sigma70 holoenzyme[J]. J Biol Chem,2013,288(13):9126-9134.
|
4 |
DEGEN D , FENG Y , ZHANG Y , et al . Transcription inhibition by the depsipeptide antibiotic salinamide A[J/OL]. Elife,2014,3:e02451.
|
5 |
ZUO Y , WANG Y , STEITZ T A . The mechanism of E. coli RNA polymerase regulation by ppGpp is suggested by the structure of their complex[J]. Mol Cell,2013,50(3):430-436.
|
6 |
HUBIN E A , FAY A, XU C , et al . Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA[J/OL]. Elife,2017,6:e22520.
|
7 |
LIN W , MANDAL S , DEGEN D , et al . Structural basis of mycobacterium tuberculosis transcription and transcription inhibition[J]. Mol Cell,2017,66(2):169-179.e8.
|
8 |
BAE B, DAVIS E , BROWN D , et al . Phage T7 Gp2 inhibition of Escherichia coli RNA polymerase involves misappropriation of sigma70 domain 1.1[J]. Proc Natl Acad Sci U S A,2013,110:19772-19777.
|
9 |
FEKLISTOV A , BAE B, HAUVER J , et al . RNA polymerase motions during promoter melting[J]. Science,2017,356(6340):863-866.
|
10 |
WEINZIERL R O . The nucleotide addition cycle of RNA polymerase is controlled by two molecular hinges in the bridge helix domain[J]. BMC Biol,2010,8:134.
|
11 |
HEIN P P , LANDICK R . The bridge helix coordinates movements of modules in RNA polymerase[J]. BMC Biol,2010,8:141.
|
12 |
WEHRLI W . Ansamycins chemistry, biosynthesis and biological activity[J]. Top Curr Chem,1977,72:21-49.
|
13 |
ROTHSTEIN D M . Rifamycins, alone and in combination[J]. Cold Spring Harb Perspect Med,2016,6(7):pii:a027011.
|
14 |
ARISTOFF P A , GARCIA G A , KIRCHHOFF P D , et al . Rifamycins—obstacles and opportunities[J]. Tuberculosis (Edinb),2010,90:94-118.
|
15 |
MOLODTSOV V , SCHARF N T , STEFAN M A , et al . Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis [J]. Mol Microbiol,2017,103(6):1034-1045.
|
16 |
CAMPBELL E A , KORZHEVA N , MUSTAEV A , et al . Structural mechanism for rifampicin inhibition of bacterial RNA polymerase[J]. Cell,2001,104(6):901-912.
|
17 |
ARTSIMOVITCH I , VASSYLYEVA M N , SVETLOV D , et al . Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins[J]. Cell,2005,122(3):351-363.
|
18 |
SMITH A B 3RD, DONG S , BRENNEMAN J B , et al . Total synthesis of (+)-sorangicin A[J]. J Am Chem Soc, 2009,131(34):12109-12111.
|
19 |
CAMPBELL E A , PAVLOVA O , ZENKIN N , et al . Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase[J]. EMBO J,2005,24(4):674-682.
|
20 |
CICILIATO I , CORTI E , SARUBBI E , et al . Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization[J]. J Antibiot (Tokyo),2004,57(3):210-217.
|
21 |
ZHANG Y , DEGEN D , HO M X, et al . GE23077 binds to the RNA polymerase 'i' and 'i+1' sites and prevents the binding of initiating nucleotides[J/OL]. Elife,2014,3:e02450.
|
22 |
MAFFIOLI S I , ZHANG Y , DEGEN D , et al . Antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase[J]. Cell,2017,169(7):1240-1248.e23.
|
23 |
SIDDHIKOL C , ERBSTOESZER J W , WEISBLUM B . Mode of action of streptolydigin[J]. J Bacteriol,1969,99(1):151-155.
|
24 |
CASSANI G , BURGESS R R , GOODMAN H M , et al . Inhibition of RNA polymerase by streptolydigin[J]. Nat New Biol,1971,230(15):197-200.
|
25 |
MCCLURE W R . On the mechanism of streptolydigin inhibition of Escherichia coli RNA polymerase[J]. J Biol Chem,1980,255(4):1610-1616.
|
26 |
TEMIAKOV D , ZENKIN N , VASSYLYEVA M N , et al . Structural basis of transcription inhibition by antibiotic streptolydigin[J]. Mol Cell,2005,19(5):655-666.
|
27 |
TUSKE S , SARAFIANOS S G , WANG X , et al . Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation[J]. Cell,2005,122(4):541-552.
|
28 |
MOORE B S , TRISCHMAN J A , SENG D , et al . Salinamides, antiinflammatory depsipeptides from a marine streptomycete[J]. J Org Chem,1999,64(4):1145-1150.
|
29 |
ARTSIMOVITCH I , CHU C , LYNCH A S , et al . A new class of bacterial RNA polymerase inhibitor affects nucleotide addition[J]. Science,2003,302(5645):650-654.
|
30 |
FENG Y , DEGEN D , WANG X , et al . Structural basis of transcription inhibition by CBR hydroxamidines and CBR pyrazoles[J]. Structure,2015,23(8):1470-1481.
|
31 |
IRSCHIK H , GERTH K , H?FLE G , et al . The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales)[J]. J Antibiot (Tokyo),1983,36(12):1651-1658.
|
32 |
MUKHOPADHYAY J , DAS K, ISMAIL S , et al . The RNA polymerase "switch region" is a target for inhibitors[J]. Cell,2008,135(2):295-307.
|
33 |
BELOGUROV G A , VASSYLYEVA M N , SEVOST-YANOVA A , et al . Transcription inactivation through local refolding of the RNA polymerase structure[J]. Nature,2009,457(7227):332-335.
|
34 |
MOLODTSOV V , FLEMING P R , EYERMANN C J , et al . X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma protein[J]. J Med Chem,2015,58(7):3156-3171.
|
35 |
CHAKRABORTY A , WANG D , EBRIGHT Y W , et al . Opening and closing of the bacterial RNA polymerase clamp[J]. Science,2012,337(6094):591-595.
|
36 |
BUURMAN E T , FOULK M A , GAO N , et al . Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzae[J]. J Bacteriol,2012,194(20):5504-5512.
|
37 |
LANCASTER J W , MATTHEWS S J . Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections[J]. Clin Ther,2012,34(1):1-13.
|
38 |
VENUGOPAL A A , JOHNSON S . Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection[J]. Clin Infect Dis,2012,54(4):568-574.
|
39 |
LIN W , DAS K, DEGEN D , et al . Structural basis of transcription inhibition by fidaxomicin (lipiarmycin A3)[J]. Mol Cell,2018,70(1):60-71.e15.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|